Fidelity International’s ProQR Therapeutics PRQR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-899,257
| Closed | -$669K | – | 862 |
|
2022
Q3 | $669K | Sell |
899,257
-158,834
| -15% | -$118K | ﹤0.01% | 736 |
|
2022
Q2 | $823K | Sell |
1,058,091
-47,002
| -4% | -$36.6K | ﹤0.01% | 730 |
|
2022
Q1 | $1M | Buy |
1,105,093
+81,268
| +8% | +$73.5K | ﹤0.01% | 735 |
|
2021
Q4 | $8.2M | Sell |
1,023,825
-181,935
| -15% | -$1.46M | 0.01% | 558 |
|
2021
Q3 | $10.1M | Buy |
1,205,760
+177,958
| +17% | +$1.49M | 0.01% | 535 |
|
2021
Q2 | $6.93M | Buy |
1,027,802
+370,340
| +56% | +$2.5M | 0.01% | 601 |
|
2021
Q1 | $4.35M | Buy |
657,462
+326,258
| +99% | +$2.16M | ﹤0.01% | 623 |
|
2020
Q4 | $1.39M | Hold |
331,204
| – | – | ﹤0.01% | 630 |
|
2020
Q3 | $1.59M | Buy |
331,204
+139,590
| +73% | +$668K | ﹤0.01% | 605 |
|
2020
Q2 | $1.17M | Buy |
191,614
+112,372
| +142% | +$683K | ﹤0.01% | 603 |
|
2020
Q1 | $435K | Buy |
79,242
+27,018
| +52% | +$148K | ﹤0.01% | 630 |
|
2019
Q4 | $518K | Buy |
52,224
+12,009
| +30% | +$119K | ﹤0.01% | 672 |
|
2019
Q3 | $232K | Buy |
+40,215
| New | +$232K | ﹤0.01% | 668 |
|